The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 03, 2015
Filed:
May. 20, 2011
Applicants:
Heidi Trusheim, Apex, NC (US);
Peter Mason, Somerville, MA (US);
Michael Franti, Ridgefield, CT (US);
Bjoern Keiner, Basel, CH;
Melissa Sackal, Dublin, IE;
Juerg Hunziker, Aarau, CH;
Francois Natt, Hesingue, CH;
David Morrissey, Cambridge, MA (US);
Inventors:
Heidi Trusheim, Apex, NC (US);
Peter Mason, Somerville, MA (US);
Michael Franti, Ridgefield, CT (US);
Bjoern Keiner, Basel, CH;
Melissa Sackal, Dublin, IE;
Juerg Hunziker, Aarau, CH;
Francois Natt, Hesingue, CH;
David Morrissey, Cambridge, MA (US);
Assignee:
Novartis AG, Basel, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 7/02 (2006.01); A61K 39/145 (2006.01); C12N 7/00 (2006.01); C12N 15/113 (2010.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/145 (2013.01); C12N 7/00 (2013.01); C12N 15/1131 (2013.01); A61K 2039/525 (2013.01); C12N 2310/14 (2013.01); C12N 2320/00 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/16152 (2013.01);
Abstract
Methods for producing reassortant viruses are provided wherein the transcription and/or translation of the hemagglutinin and/or neuraminidase genes are suppressed.